Department of Pediatrics and Developmental Biology, Graduate School of Medicine, Tokyo Medical and Dental University, Tokyo, Japan.
Blood. 2011 Mar 10;117(10):2887-90. doi: 10.1182/blood-2010-08-301515. Epub 2010 Nov 9.
Autoimmune lymphoproliferative syndrome (ALPS) is classically defined as a disease with defective FAS-mediated apoptosis (type I-III). Germline NRAS mutation was recently identified in type IV ALPS. We report 2 cases with ALPS-like disease with somatic KRAS mutation. Both cases were characterized by prominent autoimmune cytopenia and lymphoadenopathy/splenomegaly. These patients did not satisfy the diagnostic criteria for ALPS or juvenile myelomonocytic leukemia and are probably defined as a new disease entity of RAS-associated ALPS-like disease (RALD).
自身免疫性淋巴组织增生综合征(ALPS)经典定义为 Fas 介导的凋亡缺陷性疾病(I-III 型)。最近在 IV 型 ALPS 中发现了种系NRAS 突变。我们报告了 2 例具有 KRAS 突变的 ALPS 样疾病。这两例均表现为明显的自身免疫性血细胞减少症和淋巴结病/脾肿大。这些患者不符合 ALPS 或幼年髓单核细胞白血病的诊断标准,可能被定义为 Ras 相关的 ALPS 样疾病(RALD)的一种新的疾病实体。